You are invited! As part of our broader diversity, equity, and inclusion activities, we are excited to announce our partnerships with local pride institutions in the U.S. These partnerships are dedicated to supporting and raising awareness on access to vaccines that help protect individuals and safeguard communities at-risk for mpox. 🌈 Driven by our commitment to protect and save lives, we focus our efforts where we can make an impact. Come meet us at San Diego Pride, Market Days Chicago, and Atlanta Pride. #EmpoweredAgainstMpox #BavarianNordic #ProtectingandSavingLives
Om os
For us, it is all about improving and saving lives Improving and saving lives through innovative vaccines is at the heart of what we do in Bavarian Nordic, and we have more than 25 years of experience in developing life-saving vaccines. We are a fully integrated vaccine company focused on the development, manufacturing and commercialization of our vaccines- We are a global leader in smallpox and mpox vaccines, which have been developed through our long-standing partnership with the U.S. Government to enhance the public health preparedness and have a strong portfolio of vaccines for travelers and endemic diseases. Our values – our Bavarian Nordic DNA, as we call it – is what guides our actions. We act as persistent pioneers, we are embracing change, we value being boosted by the team, and we believe in protecting lives every day. If that is also a part of your DNA, we invite you to join us in Bavarian Nordic! We are a global team of more than 1,400 dedicated people with diverse backgrounds and viewpoints who are bound together by our commitment to protect lives every day. We believe in creating an inclusive and flexible workplace with a strong focus on personal and professional development, because we need each other to take things further. We operate in a world in constant flux and always explore new opportunities. So, if you are open-minded and have the willpower to succeed, we might just be a perfect fit. See your career opportunities at www.bavarian-nordic.com/careers
- Websted
-
http://www.bavarian-nordic.com
Eksternt link til Bavarian Nordic
- Branche
- Produktion af lægemidler
- Virksomhedsstørrelse
- 1.001 – 5.000 medarbejdere
- Hovedkvarter
- Copenhagen, Capital Region
- Type
- Aktieselskab
- Grundlagt
- 1994
- Specialer
- Infectious Diseases, Biodefense, Vaccine Manufacturing og Vaccines
Beliggenheder
Medarbejdere hos Bavarian Nordic
-
Reid Behrendt
Commercial Operations at Bavarian Nordic
-
Inga Margarita Coello
Ledelse, facilitering, coaching, PCC, ORSC, Certified Dare to Lead™️ Facilitator, LEGO SERIOUS PLAY facilitator
-
Kay Stendevad
Head of Business Development at Bavarian Nordic
-
Adam Guhle
Experienced commercial leader | Passionate about science and scientific communication | Oncology | Hematology | Vaccines | Precision medicine
Opdateringer
-
No slides, just dialogue and Q&A - that's the essence when our Executive Management members engage with our colleagues on what we call EMConnects. These sessions are designed to foster discussions about our choices, strategies, and goals. A few weeks ago, we had the pleasure of featuring our CCO, Jean-Christophe (JC) May. Four years ago, he joined Bavarian Nordic with the task of establishing a commercial organization. He provided a deep dive into our commercial strategy aimed at generating growth and discussed how the commercial team prioritizes the many must-win battles. We also learned why JC wears a sports watch, which is not just for show.
-
‘If you have a brain, you have a bias’ were the frank words from Sara Louise Muhr when she visited us last week to unfold the challenging concept of unconscious biases. Having celebrated diversity and inclusion over the past month together with our colleagues in BNPride, we are ready to continue the dialogue, regardless of the time of the year. We will continue to learn and explore as Sara will join us again in August for the second part of the webinar, zooming in on inclusive colleagueship. #BavarianNordic #Inclusion #DEI
-
Sustainability is an integral part of our strategy and business and now we have also converted our undrawn credit facility into a sustainability-linked loan. This means the interest rate margin will adjust based on the success of our sustainability ambitions: · Access to Medicine: Develop and execute a strategy to expand access to our vaccines. · Responsible Supply Program: Increase the number of key suppliers undergoing third-party audits on environmental, social, and governance parameters. · Greenhouse Gas Emissions: Reduce Scope 1 and 2 greenhouse gas emissions compared to our 2023 baseline. We are proud of this commitment as a significant milestone in our efforts to deliver on our sustainability ambitions. #savinglives #communities #vaccines #socialresponsiblity #sustainability #GlobalHealth #ESG
-
It calls for celebration. Over the past months, we have submitted a record-high number of regulatory submissions and succeeded with the commercial launch of our mpox vaccine in the US. Undoubtedly, these are pivotal moments for us at Bavarian Nordic, shaping the future of our company. So, what better occasion than bringing colleagues together across locations and geographies to celebrate their dedication and hard work. Here’s to many more milestones and continued success! #BavarianNordic #Boostedbytheteam #ProtectingandSavingLives #Pharma
-
We are proud to announce our commitment to support global efforts to address the mpox situation in Africa through a donation of 15,000 doses of our mpox vaccine. In partnership with Gavi, the Vaccine Alliance, World Health Organization and UNICEF we will work to facilitate the availability of doses in response to the ongoing outbreak in the DRC and other African countries. Read more: https://lnkd.in/dfKtvq-y
-
Today, we announced the submission of a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) seeking approval of our vaccine candidate for immunization to prevent disease caused by #chikungunya virus infection in individuals 12 years of age and older. “The MAA marks our second major submission in just a few weeks as part of our efforts to launch the chikungunya vaccine next year in the U.S. and Europe. Chikungunya, like other mosquito-borne infectious diseases, represents an increasing public health threat due to factors such as climate-change, but also resulting from improved disease surveillance and diagnosis. Our vaccine candidate is designed for ease of use in individuals 12 years of age and older at risk of chikungunya virus and represents an important contribution to the development of preventative solutions against this debilitating disease,” said Paul Chaplin, President and CEO of Bavarian Nordic. Read more: https://lnkd.in/dcBEp5jg
-
Join our growing team at our Manufacturing site in Kvistgaard, Denmark - we are looking for new colleagues! #hiring #boostedbytheteam
-
Say hi to our BNPride community group. BNPride is the name of our Employee Resource Group, founded by two of our employees, Mark Clarke and Virginia Fitt, with the dedication to support and raise awareness of LGBTQIA+ topics. The group consists of eight members, with fellow colleagues invited to join. They meet every two weeks to connect on lived experiences while helping spark ideas that create positive change and inclusivity. Some of our BNPride members shared their stories and why DE&I is important to them. ⬇ #PrideMonth #BNPride #Inclusion #Allyship #BavarianNordic
Tilsvarende sider
Finansiering
Seneste runde
Post IPO-egenkapital171.677.866,00 US$